Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy-Reference-Cited by-同舟云学术

Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy

Published:2021-10-26 Issue:1 Volume:40 Page:26-34
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Ariamanesh Mona¹^ORCID,Porouhan Pejman²^ORCID,PeyroShabany Babak³^ORCID,Fazilat-Panah Danial⁴^ORCID,Dehghani Mansoureh⁵^ORCID,Nabavifard Maryam⁶^ORCID,Hatami Farbod⁷^ORCID,Fereidouni Mohammad⁸^ORCID,Welsh James S.⁹^ORCID,Javadinia Seyed Alireza⁶^ORCID

Affiliation:

1. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Department of Radiation Oncology, Vasee Hospital, Sabzevar University of Medical Sciences, Sabzevar, Iran

3. Department of Internal Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

4. Cancer Research Center, Babol University of Medical Sciences, Babol, Iran

5. Neyshabur University of Medical Sciences, Neyshabur, Iran

6. Clinical Research Development Unit, Hospital Research Development Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran

7. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

8. Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran

9. Department of Radiation Oncology, Edward Hines Jr VA Hospital and Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA

Funder

Sabzevar University of Medical Sciences

Neyshabur University of Medical Sciences

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1992420

Reference23 articles.

1. COVID-19 Vaccines in Patients With Cancer—A Welcome Addition, but There Is Need for Optimization

2. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

3. COVID-19 in Cancer and Non-cancer Patients

4. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studies

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-05-24

2. Turnaround Time and Barriers in Treatment of Newly Diagnosed Cancer Patients: A Research Protocol;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

3. Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination;Expert Review of Vaccines;2023-11-10

4. Efficacy of Sinopharm Vaccine Among Stem Cell Transplant Recipients During Two Peaks of Delta and Omicron variants of COVID-19;Current Drug Safety;2023-11

5. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2;Frontiers in Medicine;2023-07-17